Clinical Trials Directory

Trials / Completed

CompletedNCT04029727

Effect of the Combination of Plant Extracts (BSL_EP025) in Cardiovascular Health

Pilot Study to Evaluate the Effect of the Consumption of a Combination of Plant Extracts (BSL_EP025) on the Levels of LDL-cholesterol and Oxidized LDL-cholesterol in Healthy Volunteers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Biosearch S.A. · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The objective of the study is to evaluate the ability of a combination of plant extracts (BSL\_EP025) to reduce the levels of LDL-cholesterol and oxidized LDL-cholesterol in individuals with LDL-cholesterol levels between 100 and 190 mg/dL.

Detailed description

There is a strong relationship between serum cholesterol levels and cardiovascular diseases, especially between coronary artery disease and LDL-cholesterol (LDL). LDL is the lipoprotein responsible for delivering cholesterol to cells. However, in recent years, special attention has been given to modified LDL, especially oxidized LDL, since it plays a very important role in the initiation and progression of the atheroma plaque. There are environmental and genetic factors that can influence the type and levels of blood lipoproteins. Among the modulable factors (environmental) it has been observed that some phytochemical compounds found in several plant extracts may reduce cardiovascular risk, due to their antioxidant and anti-inflammatory properties. The objective of the present study is to evaluate the possible effect of the intake of a combination of plant extracts (BSL\_EP025) on the levels of LDL-cholesterol and oxidized LDL-cholesterol in healthy individuals with LDL-cholesterol levels between 100 and 190 mg/dL.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCombination of Plant Extracts (BSL_EP025)Each participant will consume 2 capsules daily at lunch for 8 weeks.
DIETARY_SUPPLEMENTPlaceboEach participant will consume 2 capsules daily at lunch for 8 weeks.

Timeline

Start date
2019-05-24
Primary completion
2019-07-31
Completion
2019-07-31
First posted
2019-07-23
Last updated
2019-11-15

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04029727. Inclusion in this directory is not an endorsement.